ScholarIQanswers from OpenAlex

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses

PaperCitations, authors & open-access status

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses have?

ScholarIQcitation count

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses has 174 citations in the OpenAlex counts ScholarIQ stores.

When was Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses published?

ScholarIQyear

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses has 2019 year in the ScholarIQ index.

What is the open-access status of Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses?

ScholarIQoa status

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses has closed oa status in the ScholarIQ index.

What is the DOI of Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses?

ScholarIQdoi

The DOI for Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses is on the source record.

What is the PMID of Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses?

ScholarIQpmid

The PMID for Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses is on the source record.

What is the OpenAlex record for Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses?

ScholarIQopenalex

The OpenAlex for Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial